Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

EBR:BELYS - Euronext Brussels - BE0974314461 - Common Stock - Currency: EUR

0.7  -0.02 (-2.78%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BELYS. BELYS was compared to 31 industry peers in the Household Durables industry. While BELYS is still in line with the averages on profitability rating, there are concerns on its financial health. BELYS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BELYS was profitable.
BELYS had a positive operating cash flow in the past year.
BELYS had negative earnings in 4 of the past 5 years.
Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

BELYS has a better Return On Assets (3.30%) than 61.29% of its industry peers.
The Return On Equity of BELYS (11.07%) is better than 67.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.18%, BELYS is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BELYS is significantly below the industry average of 16.03%.
The last Return On Invested Capital (7.18%) for BELYS is above the 3 year average (7.13%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROIC 7.18%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With a Profit Margin value of 3.77%, BELYS perfoms like the industry average, outperforming 58.06% of the companies in the same industry.
The Operating Margin of BELYS (8.15%) is better than 67.74% of its industry peers.
In the last couple of years the Operating Margin of BELYS has declined.
With a decent Gross Margin value of 60.82%, BELYS is doing good in the industry, outperforming 77.42% of the companies in the same industry.
In the last couple of years the Gross Margin of BELYS has remained more or less at the same level.
Industry RankSector Rank
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BELYS is destroying value.
The number of shares outstanding for BELYS remains at a similar level compared to 1 year ago.
BELYS has a better debt/assets ratio than last year.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BELYS has an Altman-Z score of 0.34. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BELYS (0.34) is worse than 90.32% of its industry peers.
BELYS has a debt to FCF ratio of 5.56. This is a neutral value as BELYS would need 5.56 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.56, BELYS is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
BELYS has a Debt/Equity ratio of 1.64. This is a high value indicating a heavy dependency on external financing.
BELYS has a Debt to Equity ratio of 1.64. This is amonst the worse of the industry: BELYS underperforms 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Altman-Z 0.34
ROIC/WACC0.67
WACC10.78%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BELYS has a Current Ratio of 1.78. This is a normal value and indicates that BELYS is financially healthy and should not expect problems in meeting its short term obligations.
BELYS's Current ratio of 1.78 is fine compared to the rest of the industry. BELYS outperforms 61.29% of its industry peers.
BELYS has a Quick Ratio of 1.78. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BELYS (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 0.95
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 193.44% over the past year.
Looking at the last year, BELYS shows a decrease in Revenue. The Revenue has decreased by -6.82% in the last year.
The Revenue has been growing slightly by 0.43% on average over the past years.
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%

3.2 Future

BELYS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.00% yearly.
Based on estimates for the next years, BELYS will show a small growth in Revenue. The Revenue will grow by 0.59% on average per year.
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue Next Year-1.43%
Revenue Next 2Y0.18%
Revenue Next 3Y0.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 2.41, which indicates a rather cheap valuation of BELYS.
BELYS's Price/Earnings ratio is rather cheap when compared to the industry. BELYS is cheaper than 96.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of BELYS to the average of the S&P500 Index (27.30), we can say BELYS is valued rather cheaply.
BELYS is valuated cheaply with a Price/Forward Earnings ratio of 6.80.
80.65% of the companies in the same industry are more expensive than BELYS, based on the Price/Forward Earnings ratio.
BELYS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 2.41
Fwd PE 6.8
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 83.87% of the companies in the same industry.
BELYS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BELYS is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.84
EV/EBITDA 3.61
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.94%
EPS Next 3Y4%

0

5. Dividend

5.1 Amount

No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield N/A

BELYSSE GROUP NV

EBR:BELYS (7/8/2025, 7:00:00 PM)

0.7

-0.02 (-2.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)04-25 2025-04-25
Earnings (Next)09-05 2025-09-05
Inst Owners14.18%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap25.16M
Analysts84.44
Price Target1.63 (132.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.82%
Valuation
Industry RankSector Rank
PE 2.41
Fwd PE 6.8
P/S 0.09
P/FCF 0.84
P/OCF 0.63
P/B 0.26
P/tB N/A
EV/EBITDA 3.61
EPS(TTM)0.29
EY41.43%
EPS(NY)0.1
Fwd EY14.71%
FCF(TTM)0.83
FCFY118.97%
OCF(TTM)1.12
OCFY159.52%
SpS7.8
BVpS2.66
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.3%
ROE 11.07%
ROCE 8.77%
ROIC 7.18%
ROICexc 8.43%
ROICexgc 17.07%
OM 8.15%
PM (TTM) 3.77%
GM 60.82%
FCFM 10.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexcg growth 3Y21.04%
ROICexcg growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score6
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 5.56
Debt/EBITDA 3.69
Cap/Depr 52.09%
Cap/Sales 3.64%
Interest Coverage 1.06
Cash Conversion 94.56%
Profit Quality 283.09%
Current Ratio 1.78
Quick Ratio 0.95
Altman-Z 0.34
F-Score6
WACC10.78%
ROIC/WACC0.67
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)193.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.25%
EPS Next Y-58.33%
EPS Next 2Y-20.94%
EPS Next 3Y4%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.64%
Revenue Next Year-1.43%
Revenue Next 2Y0.18%
Revenue Next 3Y0.59%
Revenue Next 5YN/A
EBIT growth 1Y65.79%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year86.36%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y55.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.24%
OCF growth 3YN/A
OCF growth 5YN/A